Peanut allergy

Milind Pansare1, Deepak Kamat

  • 1Division of Allergy/Immunology, Wayne State University, and Pediatric Residency Program, The Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, Michigan 48201, USA. mpansare@dmc.org

Insights

Peanut allergy management is advancing, with oral immunotherapy showing promise for desensitization. Research also explores early introduction of peanut protein to build tolerance in infants.

Area of Science:

  • Allergy and Immunology
  • Pediatric Medicine
  • Clinical Research

Background:

  • Peanut allergy is increasingly prevalent in children, particularly in developed nations.
  • The exact causes for the rising prevalence remain under investigation, with various environmental and specific factors hypothesized.
  • Current management focuses on strict peanut avoidance and emergency treatment for anaphylaxis.

Purpose of the Study:

  • To review and highlight recent breakthroughs in the clinical management of peanut allergy.
  • To discuss emerging diagnostic tools and therapeutic strategies for peanut allergy.

Main Methods:

  • Review of recent clinical trials and prospective studies on peanut allergy management.
  • Analysis of data from studies investigating peanut oral immunotherapy (OIT).
  • Examination of research on early dietary interventions, such as the LEAP study.

Main Results:

  • Peanut oral immunotherapy (OIT) trials have demonstrated successful desensitization in participants.
  • Ongoing studies are evaluating the impact of early high-dose peanut protein introduction versus avoidance in high-risk infants.
  • Component-resolved diagnostics are being developed to better assess clinical sensitivity.

Conclusions:

  • Currently, there is no definitive cure for peanut allergy.
  • Peanut oral immunotherapy presents a viable therapeutic option for achieving desensitization.
  • Further research into immunotherapeutic approaches is underway in both human and animal models.
Abstract

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
28.7K
Allergic Reactions02:06

Allergic Reactions

Overview
26.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
278